𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Controlled clinical trial to assess the response of recent heroin abusers with chronic hepatitis C virus infection to treatment with interferon alpha-n2b

✍ Scribed by Sergio Neri; Cosimo M. Bruno; Giuseppe Abate; Dario Ierna; Barbara Mauceri; Danila Cilio; Fabio Bordanaro; Davide Pulvirenti; Claudio Italiano; Luciano Caruso

Book ID
117321241
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
591 KB
Volume
24
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Variants in interferon-alpha pathway gen
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial
✍ Tania Mara Welzel; Timothy R. Morgan; Herbert L. Bonkovsky; Deepa Naishadham; Ru πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 270 KB πŸ‘ 2 views

Combination treatment with pegylated-interferon-alpha (PEG IFN-␣) and ribavirin, the current recommended therapy for chronic hepatitis C virus (HCV) infection, results in a sustained virological response (SVR) in only about half of patients. Because genes involved in the interferon-alpha pathway may

Lymphoblastoid interferon alfa-n1 improv
Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial
✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l